Iodine-131 labeled genistein as a potential radiotracer for breast cancer
Authors:
- Danni RamdhaniDRDanni Ramdhani
- Eva Maria WidyasariEWEva Maria Widyasari
- Maula Eka SriyaniMSMaula Eka Sriyani
- Quinzheilla Putri ArnandaQAQuinzheilla Putri Arnanda
- Hiroshi WatabeHWHiroshi Watabe
Open Access
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Molecular docking of genistein on estrogen receptors, promoter region of BCLX, caspase-3, Ki-67, cyclin D1, and telomere activityJournal of Taibah University Medical Sciences, 2018
- An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist positionScientific Reports, 2017
- Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of GenisteinNutrition and Cancer, 2015
- Genistein and Cancer: Current Status, Challenges, and Future DirectionsAdvances in Nutrition, 2015
- Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapyCanadian Medical Association Journal, 2010
- Genistein in the Presence of 17β-Estradiol Inhibits Proliferation of ERβ Breast Cancer CellsPharmacology, 2009
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Human radiolabeled mass balance studies: objectives, utilities and limitationsBiopharmaceutics & Drug Disposition, 2009
- Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) statusEuropean Journal of Pharmacology, 2008
- Soy isoflavones and immunityThe Journal of Medical Investigation, 2008